• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Physical therapy yields modest improvements in chronic low back pain

byAdrian WongandMichaela Dowling
April 20, 2026
in Chronic Disease, Emergency, Rheumatology
Reading Time: 3 mins read
Reduced gestational weight gain with lifestyle intervention
Share on FacebookShare on Twitter

1. In this randomized controlled trial, physical therapy (PT) was associated with a modest improvement in function compared with cognitive behavioural therapy (CBT) as a first-line treatment for chronic low back pain (cLBP).

2. Patients treated with PT reported greater improvements in anxiety, fatigue, pain interference, physical function, sleep disturbance, and social role performance.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Current guidelines recommend initial non-pharmacologic management of chronic low back pain (cLBP), including physiotherapy (PT), cognitive behavioural therapy (CBT), and mindfulness-based approaches. However, treatment effects are often heterogeneous in real-world practice, and there is limited guidance on optimal first-line selection or sequencing of therapies. This study compared PT and CBT as first-stage interventions and evaluated mindfulness versus treatment switching as second-stage options for patients with cLBP. At 10 weeks, PT was associated with a modest improvement in physical function compared with CBT, although there were no statistically or clinically significant differences in pain intensity. The functional benefit did not reach the minimally important difference but was consistent across sensitivity analyses. PT was also associated with broader improvements in patient-reported outcomes, including anxiety, fatigue, pain interference, sleep disturbance, physical function, and social participation, while depression scores were similar between groups. Patients receiving PT required fewer injections, although there were no meaningful differences in opioid use, imaging, surgery, or emergency department visits. Among participants who did not respond to initial therapy, neither mindfulness nor treatment switching resulted in significant differences in pain or function. Limitations include lower-than-expected treatment uptake and follow-up, lack of blinding, and a relatively small sample size, which may limit generalizability. Overall, these findings suggest that PT may offer modest advantages over CBT as a first-line treatment for cLBP, particularly in improving function and broader patient-reported outcomes.

Click to read this study in AIM

Relevant Reading: Evidence-based interventions to treat chronic low back pain: treatment selection for a personalized medicine approach

RELATED REPORTS

A neurostimulation intervention may improve pain in patients with chronic low back pain

2 Minute Medicine Rewind August 17, 2026

2 Minute Medicine Rewind July 13, 2026

In-Depth [randomized controlled trial]: This study compared physiotherapy (PT) and cognitive behavioural therapy (CBT) as first-line treatments for chronic low back pain (cLBP), and evaluated mindfulness versus treatment switching as second-stage options for initial non-responders. Participants were recruited from three U.S. health systems between March 2019 and September 2023, with a temporary pause during the COVID-19 pandemic. Eligible adults were aged 18–64 years with low back pain lasting at least 3 months, pain on ≥50% of days in the prior 6 months, recent healthcare utilization for back pain, pain intensity ≥4/10, and an Oswestry Disability Index (ODI) ≥24. Exclusion criteria included serious spinal pathology, recent surgery, pregnancy, recent participation in similar interventions, or active substance use disorder treatment. The primary outcomes were back pain–related function (ODI) and pain intensity (0–10 scale). Secondary outcomes included PROMIS-29 health domains, opioid use, and healthcare utilization. A total of 749 participants were randomized (375 CBT, 374 PT). At 10 weeks, 576 participants (76.9%) completed follow-up. Response rates were higher with PT than CBT (24.7% vs 13.6%), with CBT participants less likely to respond (RR 0.55, 95% CI 0.39–0.79). Treatment initiation occurred in 63.2% overall. At 10 weeks, PT showed a small but statistically significant improvement in function compared with CBT (adjusted mean difference 2.8 points on ODI), though this was below the minimally important difference. No significant difference was seen in pain intensity. Sensitivity analyses confirmed the robustness of functional findings. PT was associated with greater improvements in anxiety, fatigue, pain interference, sleep disturbance, physical function, and social participation, with minimal differences in depression. Fewer patients in the PT group received injections compared with CBT (4.2% vs 11.3%). There were no meaningful differences in opioid use, imaging, surgery, or emergency department visits. Among initial non-responders, mindfulness and treatment switching did not differ significantly across outcomes. Serious adverse events were rare and similar between groups. Overall, PT may provide modest functional advantages over CBT as first-line therapy for cLBP.

Image: PD

©2026 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: back painback pain therapyCBTchronic lower back painmindfullnessphysical therapy
Previous Post

Proximal hypoglossal nerve stimulation found effective for obstructive sleep apnea

Next Post

Increasing the volume of pericapsular nerve block may not improve postoperative pain control after total hip arthroplasty

RelatedReports

Epidural corticosteroid injections provide only short-term radiculopathy pain relief
Chronic Disease

A neurostimulation intervention may improve pain in patients with chronic low back pain

August 17, 2026
Low free sugar diet reduces hepatic steatosis in nonalcoholic fatty liver disease in adolescent males
Weekly Rewinds

2 Minute Medicine Rewind August 17, 2026

August 17, 2026
Assessment of Combined Nivolumab and Bevacizumab in Relapsed Ovarian Cancer: A Phase 2 Clinical Trial
Weekly Rewinds

2 Minute Medicine Rewind July 13, 2026

July 13, 2026
Chronic Disease

Behavioral support does not improve patient-directed opioid tapering success

July 6, 2026
Next Post
Social networks play key roles in parental vaccination decisions

Increasing the volume of pericapsular nerve block may not improve postoperative pain control after total hip arthroplasty

Prenatal antidepressant exposure may increase risk of poor motor development

Pelvic floor muscle training may reduce postpartum stress urinary incontinence

The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!

The Scan by 2 Minute Medicine®: TikTok "Fibermaxxing" trend targets gut microbiome diversity, Jennifer Aniston’s "Strength for 50+" ritual spotlights photobiomodulation, American Lung Association issues respiratory warning over viral "mouth taping" fad, and Psychiatric Times highlights initiative to close the schizophrenia mortality gap

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Daraxonrasib extends survival in metastatic pancreatic cancer
  • Artificial intelligence (AI) scribes showed mixed effects on documentation time and improvements in physician well-being
  • A lower threshold for referral to the emergency department for outpatient hyperkalemia may reduce mortality
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.